Interlocking
发表于 2025-3-26 22:28:17
http://reply.papertrans.cn/16/1586/158539/158539_31.png
震惊
发表于 2025-3-27 01:07:27
http://reply.papertrans.cn/16/1586/158539/158539_32.png
植物茂盛
发表于 2025-3-27 05:37:13
http://reply.papertrans.cn/16/1586/158539/158539_33.png
capsaicin
发表于 2025-3-27 09:38:16
http://reply.papertrans.cn/16/1586/158539/158539_34.png
品尝你的人
发表于 2025-3-27 15:17:25
http://reply.papertrans.cn/16/1586/158539/158539_35.png
Palate
发表于 2025-3-27 19:47:51
The Blood–Brain Barrier and the Design of New Antiepileptic Drugs
防水
发表于 2025-3-27 23:01:16
http://reply.papertrans.cn/16/1586/158539/158539_37.png
JADED
发表于 2025-3-28 03:40:41
Synaptic Vesicle Protein 2A as a Novel Pharmacological Target with Broad Potential for New Antiepileof the role of SV2A in epilepsy, addressing three main issues: SV2A function in neurotransmission, the correlation of the expression and/or distribution of the protein with treatment response and neuronal damage, and the reasons that SV2A is a good molecular target for the discovery of new antiepile
entice
发表于 2025-3-28 06:25:57
Glutamate Receptors as Targets for Novel Antiepileptic Drug Therapyharmacological blockade of glutamatergic signaling represents an attractive alternative for the control of seizures and neuroprotection. In particular, glutamate receptors are attractive targets for novel antiepileptic drugs because different studies have demonstrated that its agonists and antagonis
chronicle
发表于 2025-3-28 12:33:33
http://reply.papertrans.cn/16/1586/158539/158539_40.png